UK markets closed

Immunicum AB (publ) (IMMU.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
0.5000-0.0090 (-1.77%)
At close: 05:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
92,653
92,653
87,049
85,796
47,883
Selling general and administrative
37,051
37,051
48,876
43,490
38,080
Total operating expenses
101,489
101,489
134,696
129,277
85,963
Operating income or loss
-101,489
-101,489
-134,696
-129,277
-85,963
Interest expense
3,115
3,115
5,264
3,323
3,220
Income before tax
-101,619
-101,619
-138,785
-133,410
-89,248
Income tax expense
0
0
0
0
0
Income from continuing operations
-101,619
-101,619
-138,785
-133,410
-89,248
Net income
-101,619
-101,619
-138,785
-133,410
-89,248
Net income available to common shareholders
-101,619
-101,619
-138,785
-133,410
-89,248
Basic EPS
-0.34
-0.22
-0.70
-0.67
-1.08
Diluted EPS
-0.34
-0.22
-0.70
-0.67
-1.08
Basic average shares
863,148
462,551
199,401
199,750
82,747
Diluted average shares
863,148
462,551
199,401
199,750
82,747